OCSAW supply chain intelligence for Oculis Holding AG: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Oculis Holding AG (OCSAW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| NVSEF | Novartis AG | 72% | us to fund current planned operations beyond the next twelve months from the date of this Annual Report without additional capital. We have based our estimate on assumptions that may prove to be wron… |
| NVSEF | Novartis AG | 72% | Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCSAW graph: us to fund current planned operations beyond the next twelve months from the date of this Annual Report without add… |
| ORANY | ORANY | 72% | Accure Agreement with immediate effect upon written notice to us if we file any action to invalidate any of the licensed patents or fail to maintain the licensed patents in major countries of the ter… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from OCSAW graph: Accure Agreement with immediate effect upon written notice to us if we file any action to invalidate any of the lic… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| NVSEF | Novartis AG | 72% | us to fund current planned operations beyond the next twelve months from the date of this Annual Report without additional capital. We have based our estimate on assumptions that may prove to be wron… |
| NVSEF | Novartis AG | 72% | Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCSAW graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from OCSAW graph: us to fund current planned oper… |
| ORANY | ORANY | 72% | Accure Agreement with immediate effect upon written notice to us if we file any action to invalidate any of the licensed patents or fail to maintain the licensed patents in major countries of the ter… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from OCSAW graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from OCSAW graph: Accure Agreement with immediate… |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| NVSEF | Novartis AG | 100.00 | 1 | ['customer', 'supplier'] |
| ORANY | ORANGE | 100.00 | 1 | ['customer', 'supplier'] |
| BCDRF | Banco Santander, S.A. | 50.00 | 2 | |
| BLTE | Belite Bio, Inc | 50.00 | 2 | |
| ASBPW | Aspire Biopharma Holdings, Inc. | 50.00 | 2 | |
| BFRGW | BullFrog AI Holdings, Inc. | 50.00 | 2 | |
| BFRIW | Biofrontera Inc. | 50.00 | 2 | |
| CMCM | Cheetah Mobile Inc. | 50.00 | 2 | |
| AMZE | Amaze Holdings, Inc. | 50.00 | 2 | |
| CTNM | Contineum Therapeutics, Inc. | 50.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 50.00 | 2 | |
| ARQQW | Arqit Quantum Inc. | 50.00 | 2 | |
| AYTU | Aytu BioPharma, Inc. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 50.00 | 2 | |
| AMXOF | AMERICA MOVIL SAB DE CV/ | 50.00 | 2 | |
| D | Dominion Energy, Inc. | 50.00 | 2 | |
| CINGW | Cingulate Inc. | 50.00 | 2 | |
| DARE | Daré Bioscience, Inc. | 50.00 | 2 | |
| BDRX | Biodexa Pharmaceuticals Plc | 50.00 | 2 |